The injection itself — what happens on the day

On the morning of the appointment, patients arrive at clinic — locally in Grantham or Sleaford — have the hip numbed with local anaesthetic, and walk out the same day. There is no theatre admission, no general anaesthetic, and no surgical wound. Under ultrasound guidance, ChondroFiller™ (Liquid Cartilage™) is placed precisely into the damaged area of the hip joint; the hip does not need to be drained dry beforehand, which spares the joint unnecessary disturbance.

Once in position, the gel sets within approximately three to five minutes by bonding with fibrin already present in the joint — before the patient leaves the appointment room.

Think of the scaffold as temporary biological scaffolding erected inside the joint. The body does the building work: progenitor cells migrate in from the surrounding tissue and the bone beneath the joint surface over the days and weeks that follow, gradually maturing into cartilage-forming cells. This process — acellular matrix-induced chondrogenesis — supports the body's own repair rather than replacing damaged tissue directly.

ChondroFiller™ is suitable for focal Grade III/IV hip cartilage defects and more diffuse Kellgren-Lawrence Grade III/IV hip wear. No absolute age ceiling applies, and a 'bone-on-bone' hip does not automatically disqualify a patient.

Hours 0–48: what the hip feels like immediately after

For most patients, the hours after the injection are unremarkable — and that is entirely expected.

The hip joint has been entered with a needle and a collagen scaffold has been introduced, so a mild synovial reaction is the body doing exactly what it should. Typical sensations in the first 24–48 hours include:

• A feeling of fullness or pressure deep in the hip
• Localised soreness around the injection site
• Stiffness, particularly when rising from a chair or after sitting for a while

None of these signals a complication. Paracetamol manages discomfort for most patients in this window; NSAIDs are an option if needed, but discuss timing with the treating clinician, as their anti-inflammatory action may theoretically interact with the early repair environment.

On the day itself, avoid driving, strenuous activity, or prolonged standing. Rest is appropriate, but staying completely still tends to worsen stiffness — brief, gentle walks on flat ground from the outset help maintain hip circulation without loading the joint significantly. Most patients return home without assistance.

If swelling or pain is severe, markedly worsening, or has not begun to settle within 48 hours, contact the clinic directly.

Weeks 1–6: the Protect phase

The six weeks that follow the injection are a deliberate stabilisation window rather than a period of enforced rest. The collagen scaffold has gelled, but it still needs time to anchor securely and to begin drawing progenitor cells in from the surrounding synovium and subchondral bone — the biological process that sets cartilage repair in motion. Loading the hip too aggressively too early risks disrupting that cell migration before the matrix has taken hold.

What to avoid

Impact loading, purposeful exercise, prolonged standing, and any movement that drives high compressive force through the hip joint should be set aside for the full six weeks. Running, sport-specific training, and gym-based lower-limb work all fall into this category.

What to continue

Ordinary walking on flat ground is not only permitted but actively encouraged throughout this phase. Keeping still intensifies stiffness and reduces joint circulation; short, gentle walks maintain both without placing meaningful compressive load through the damaged area. Most patients manage light desk work and routine daily tasks within the first few days.

Driving and practical considerations

Driving restrictions depend on which hip received the injection and how quickly confident, pain-free control returns. The right hip typically requires a longer pause than the left for manual-transmission drivers. Individual recovery guides the exact timing, and the treating clinician will advise at discharge.

Full weight-bearing through daily life is, for most patients, possible from the outset — the constraint is on loading intensity, not on movement itself.

Weeks 6–12: the Strengthen phase

Six weeks is a genuine turning point. The scaffold has had time to stabilise, progenitor cells are already migrating into the collagen matrix, and the hip joint is ready to begin bearing progressively greater loads under supervision. Most patients notice the shift — both in what the hip tolerates and in what the recovery programme asks of them.

Supervised physiotherapy typically begins at this stage, targeting the hip abductors, external rotators, and core musculature that control how load is distributed across the joint. These are not peripheral exercises added for general fitness: the mechanical environment created by stronger surrounding muscles directly influences the quality of the tissue forming inside the defect. Physiotherapy at this phase is part of the repair process, not background care.

Low-impact activities — swimming, static or road cycling, and targeted hip strengthening — are introduced progressively under physiotherapy guidance. Timing and intensity are adjusted to the individual; defect size and baseline muscle strength both affect how quickly activities can be advanced.

Biologically, this window aligns with a critical maturation period. The progenitor cells that migrated into the scaffold during the Protect phase begin differentiating into chondrocyte-like cells and laying down new cartilage matrix. Pain relief, which may have begun improving from around weeks four to eight, often consolidates during this period — though individual variation is real and should be expected.

Full sports recovery typically takes approximately one year. Feeling well at week eight is encouraging; it is not a signal that loading can be accelerated without guidance.

Beyond 12 weeks: how repair continues over the following months

The twelve-week milestone marks the close of the early rehabilitation arc, not the end of repair. Inside the joint, the biological process continues on its own schedule well into the second year.

Months 2–6: Functional Loading

From roughly month two, the programme advances to longer walks, gentle cycling, and gradual reintroduction of low-impact sport-specific movement — paced by physiotherapy guidance and the hip's own response. This Functional Loading phase builds on the muscle strength established in weeks 6–12 and prepares the joint for the demands of everyday and recreational activity.

Months 6–12 and beyond

The collagen scaffold is progressively replaced by the patient's own maturing cartilage over 12–24 months. By the end of that window, the ChondroFiller™ matrix has given way entirely to endogenous tissue — the structural goal the treatment set in motion on injection day. Cartilage maturation continues through this period, which is why higher-demand activity and sport are typically reintroduced around the one-year mark rather than earlier.

The published ChondroFiller™ evidence base, which spans hip and other joint applications, reports 70–85% of treated patients achieving meaningful symptom relief at three to five years. In practical terms, that represents a sustained reduction in hip pain with function that continues improving beyond the first year rather than plateauing at it — the repair process is not a sprint that finishes at week twelve.

Lincolnshire Hip is part of the MSK Doctors group and accepts patients without referral for hip assessment, including a structured conversation about realistic timescales for individual circumstances.

Getting ChondroFiller hip treatment in Lincolnshire

Professor Paul Lee delivers ChondroFiller™ hip injections at clinics in Grantham and Sleaford under the Lincolnshire Hip platform, removing the need to travel to London for treatment. Appointments do not require a GP referral — patients can self-refer directly for a hip assessment.

When weighing up injection options, it helps to know that the three pathways offered by Lincolnshire Hip — ChondroFiller™, Arthrosamid, and PRP — work through entirely different mechanisms and are not interchangeable alternatives. ChondroFiller™ is a collagen scaffold that supports endogenous repair; Arthrosamid is a permanent hydrogel that cushions the joint rather than regenerating tissue; PRP delivers concentrated growth factors drawn from the patient's own blood. Each has a distinct clinical role, and in some cases more than one may be relevant — a clinical assessment determines which fits the individual circumstances.

The injectable ChondroFiller™ pathway carries a substantially shorter recovery arc than surgical cartilage repair, making it relevant for patients who are not yet at the stage of hip replacement and prefer to avoid theatre admission entirely.

Lincolnshire Hip is part of the MSK Doctors group and accepts patients without referral for hip assessment.